Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose
Clinical trial NCT03933852 · UNKNOWN
Trial details
- NCT number
- NCT03933852
- Sponsor
- University of Jena
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2015-07-08
- Primary completion
- 2024-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.